Tumor‐reactive CD8<sup>+</sup> T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survivalJulia Karbach, Elke Jäger, Armin Bender et al.|International Journal of Cancer|2009Cited by 113